Follow
Mark Bigham
Mark Bigham
Canadian Blood Services, Fraser Health Authority, University of British Columbia
Verified email at blood.ca
Title
Cited by
Cited by
Year
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
PG Van Buynder, S Konrad, JL Van Buynder, E Brodkin, M Krajden, ...
Vaccine 31 (51), 6122-6128, 2013
1782013
Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease
M Bigham, R Copes
Drug Safety 28, 89-101, 2005
1212005
Public health and hepatitis C
DM Patrick, JA Buxton, M Bigham, RG Mathias
Canadian Journal of Public Health/Revue Canadienne de Sante'e Publique, S18-S21, 2000
702000
Hepatitis E in Canadian blood donors
MA Fearon, SF O'Brien, G Delage, V Scalia, F Bernier, M Bigham, ...
Transfusion 57 (6), 1420-1425, 2017
492017
Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students
DM Patrick, M Bigham, H Ng, R White, A Tweed, DM Skowronski
The Pediatric infectious disease journal 22 (10), 874-878, 2003
452003
Neisseria meningitidis Carriage during an Outbreak of Serogroup C Disease
DM Patrick, S Champagne, SH Goh, G Arsenault, E Thomas, C Shaw, ...
Clinical infectious diseases 37 (9), 1183-1188, 2003
422003
Uptake and behavioural and attitudinal determinants of immunization in an expanded routine infant hepatitis B vaccination program in British Columbia
M Bigham, VP Remple, K Pielak, C McIntyre, R White, W Wu
Canadian Journal of Public Health 97, 90-95, 2006
402006
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
AJ Pollard, J Ochnio, M Ho, M Callaghan, M Bigham, S Dobson
Emerging infectious diseases 10 (10), 1812, 2004
372004
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013
M Murti, M Krajden, M Petric, J Hiebert, F Hemming, B Hefford, M Bigham, ...
Eurosurveillance 18 (49), 20649, 2013
322013
Potential Capsule Switching from Serogroup Y to B: The Characterization of Three such Neisseria meningitidis Isolates Causing Invasive Meningococcal Disease …
RSW Tsang, DKS Law, SD Tyler, GS Stephens, M Bigham, WD Zollinger
Canadian Journal of Infectious Diseases and Medical Microbiology 16, 171-174, 2005
302005
Diffuse lamellar keratitis complicating laser in situ keratomileusis: post-marketing surveillance of an emerging disease in British Columbia, Canada, 2000–2002
M Bigham, CL Enns, SP Holland, J Buxton, D Patrick, S Marion, ...
Journal of Cataract & Refractive Surgery 31 (12), 2340-2344, 2005
272005
Relation between hospital HIV/AIDS caseload and mortality among persons with HIV/AIDS in Canada
RS Hogg, J Raboud, M Bigham, JSG Montaner
Clinical and investigative medicine 21 (1), 27, 1998
261998
Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods
A Blasig, EC Wagner, D Pi, M Bigham, VP Remple, KJP Craib, P Doyle, ...
Canadian journal of public health 102, 98-102, 2011
242011
Modelling the costs and effects of a universal infant immunization program using conjugated pneumococcal vaccine in British Columbia.
D Moore, M Bigham, D Patrick
242003
Exposure to thimerosal in vaccines used in Canadian infant immunization programmes, with respect to risk of neurodevelopmental disorders.
M Bigham, R Copes, L Srour
232002
Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism?
B Strauss, M Bigham
222001
An outbreak of mumps among young adults in Vancouver, British Columbia, associated with ‘rave’parties
J Buxton, C Craig, P Daly, M Bigham, A Bell, M Fyfe
Canadian journal of public health 90, 160-163, 1999
191999
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study
J Van Schalkwyk, M Nourmoussavi, A Massey, R Gustafson, E Brodkin, ...
Canadian Journal of Gastroenterology and Hepatology 28, 525-528, 2014
172014
Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women
M Dawar, DM Patrick, M Bigham, D Cook, M Krajden, H Ng
CMAJ 168 (6), 703-704, 2003
152003
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections: summary
RR Sharma, M Lozano, M Fearon, M Bigham, R Djoudi, P Gallian, ...
Vox sanguinis 112 (4), 388-396, 2017
142017
The system can't perform the operation now. Try again later.
Articles 1–20